Atopic diseases or allergies are characterized by chronic and often hereditary, and have as a symptom hypersensitivity of the skin and / or mucous membranes to certain substances to which the patient is allergic.
Although allergy to combat these diseases are already used, specializing in medicine Allergology has introduced a new product to treat allergies: Ac monoclonal anti Ig E.
How the new anti - allergy
It is a humanized monoclonal antibody that selectively binds immunoglobulin IgE, which is in the patient's blood, to block the allergic response, helping to control the symptoms of allergic diseases.
What is atopic diseases
The main objective of the product is bronchial asthma treat severe as it has little response to conventional treatments and requires a high level of corticoids. Thus, this antibody is intended that the patient reduce the need for steroids and prevent the development of asthma, improving their quality of life.
Furthermore, the antiallergic is also effective in the treatment of chronic urticaria and food in immunotherapy. In this condition, it was found that the antibody significantly reduces the probability of allergic reactions to peanuts. Thus, the effectiveness of this product can significantly reduce the total cost of food immunotherapy.